Symbols / HIMS $24.35 -2.15%
HIMS Chart
About
Hims & Hers Health, Inc. operates as a consumer-first health and wellness platform that connects consumers to licensed healthcare professionals in the United States, the United Kingdom, Canada, Germany, the Republic of Ireland, France, Spain, and internationally. The company offers a range of curated prescription and non-prescription health and wellness products and services available to purchase on its websites and mobile application directly by customers. It also provides personalized health and wellness products; over-the-counter drug and device products, cosmetics, and supplement products primarily focusing on general wellness, skincare, sexual health and wellness, and hair care under the Hims & Hers brand name; and laboratory testing services to measure a set of biomarkers. Additionally, it offers medical consultation, post-consultation support services, and delivery of laboratory testing results services. Further, the company provides treatments and products for various chronic conditions related to hormone health, weight loss, dermatology, and mental health. The company offers its products through retail partnerships, in stores, and online. Hims & Hers Health, Inc. is based in San Francisco, California.
Fundamentals
Scroll to Statements| Sector | Healthcare | Industry | Drug Manufacturers - Spe | Market Cap | 5.55B |
| Enterprise Value | 6.21B | Income | 128.37M | Sales | 2.35B |
| Book/sh | 2.38 | Cash/sh | 2.53 | Dividend Yield | — |
| Payout | 0.00% | Employees | 2442 | IPO | — |
| P/E | 47.74 | Forward P/E | 16.24 | PEG | — |
| P/S | 2.36 | P/B | 10.23 | P/C | — |
| EV/EBITDA | 35.38 | EV/Sales | 2.65 | Quick Ratio | 1.51 |
| Current Ratio | 1.90 | Debt/Eq | 207.16 | LT Debt/Eq | — |
| EPS (ttm) | 0.51 | EPS next Y | 1.50 | EPS Growth | -17.40% |
| Revenue Growth | 28.40% | Earnings | 2026-05-04 | ROA | 5.29% |
| ROE | 25.23% | ROIC | — | Gross Margin | 73.83% |
| Oper. Margin | 2.72% | Profit Margin | 5.47% | Shs Outstand | 219.56M |
| Shs Float | 208.04M | Short Float | 46.09% | Short Ratio | 2.34 |
| Short Interest | — | 52W High | 70.43 | 52W Low | 13.74 |
| Beta | 2.61 | Avg Volume | 31.88M | Volume | 16.77M |
| Target Price | $23.12 | Recom | Hold | Prev Close | $24.88 |
| Price | $24.34 | Change | -2.15% |
Valuation Models
Price estimates from analyst targets and simple models.
1. Analyst consensus
$23.12
Mean price target
2. Current target
$25.02
Latest analyst target
3. DCF / Fair value
$9.06
Simplified: (Free Cash Flow ÷ Shares) × 18 (P/FCF multiple). Not a …
Ratings
Current target
$25.02
Low
$16.00
High
$30.00
Mean
$23.12
Latest analyst rating changes
| Date | Action | Analyst | Rating Change | Price Target |
|---|---|---|---|---|
| 2026-03-16 | main | Leerink Partners | Market Perform → Market Perform | $25 |
| 2026-03-11 | main | Barclays | Overweight → Overweight | $29 |
| 2026-03-10 | up | Citigroup | Sell → Neutral | $24 |
| 2026-03-10 | main | Deutsche Bank | Hold → Hold | $28 |
| 2026-03-10 | up | B of A Securities | Underperform → Neutral | $23 |
| 2026-03-09 | up | Needham | Hold → Buy | $30 |
| 2026-02-25 | main | Barclays | Overweight → Overweight | $25 |
| 2026-02-25 | main | Morgan Stanley | Equal-Weight → Equal-Weight | $21 |
| 2026-02-24 | main | Leerink Partners | Market Perform → Market Perform | $18 |
| 2026-02-24 | down | BTIG | Buy → Neutral | — |
| 2026-02-24 | main | Citigroup | Sell → Sell | $13 |
| 2026-02-24 | main | TD Cowen | Hold → Hold | $17 |
| 2026-02-24 | reit | Truist Securities | Hold → Hold | $18 |
| 2026-02-24 | main | Evercore ISI Group | In-Line → In-Line | $24 |
| 2026-02-09 | main | TD Cowen | Hold → Hold | $20 |
| 2026-02-09 | main | Citigroup | Sell → Sell | $17 |
| 2026-02-09 | main | B of A Securities | Underperform → Underperform | $21 |
| 2026-02-02 | main | BTIG | Buy → Buy | $60 |
| 2026-01-12 | init | Evercore ISI Group | — → In-Line | $33 |
| 2025-12-09 | init | Barclays | — → Overweight | $48 |
- Why the Novo Nordisk and Hims & Hers Deal Is a Win for Both Stocks - Yahoo Finance Mon, 16 Mar 2026 13
- Hims & Hers Health Stock Slips After Surging 50% In A Month - Benzinga Mon, 16 Mar 2026 15
- Is Hims & Hers Health, Inc. (HIMS) A Good Stock To Buy Now? - Yahoo Finance Mon, 16 Mar 2026 01
- Hims & Hers (HIMS) Soars 57.4% on New Deal - Yahoo Finance Sun, 15 Mar 2026 09
- Hims to stop offering GLP-1 pill after FDA warned of crackdown - Reuters Mon, 09 Feb 2026 08
- Novo Nordisk says it will take legal action after Hims & Hers reveals $49 copy of Wegovy pill - CNBC hu, 05 Feb 2026 08
- Novo’s Launch of Weight-Loss Pill Spoiled by Hims’ Copycat - Bloomberg.com hu, 05 Feb 2026 08
- Novo Nordisk to Sell Weight-Loss Drugs Through Hims & Hers - WSJ Mon, 09 Mar 2026 07
- Hims shares plunge after FDA threatens action on 'illegal copycat drugs' - Reuters hu, 05 Feb 2026 08
- Hims & Hers' $49 weight-loss pill jolts everyone, except its stock - Reuters Fri, 06 Feb 2026 08
- Barclays Raises PT on Hims & Hers Health (HIMS) Stock - Yahoo Finance Fri, 13 Mar 2026 15
- Hims shares set for record week as Novo partnership fuels optimism - Modern Healthcare Fri, 13 Mar 2026 16
- Hims & Hers Announces Strategic Shift for US Weight Loss Business - HIMS Investor Relations Mon, 09 Mar 2026 12
- Hims & Hers stock jumps on potential pact with Novo Nordisk (HIMS:NYSE) - Seeking Alpha Mon, 09 Mar 2026 07
- Hims & Hers Stock Soars. Its Weight-Loss Drug Battle With Novo Nordisk Takes a Surprising Twist. - Barron's Mon, 09 Mar 2026 17
Insider Transactions
| Date | Shares | Value | Url | Text | Insider | Position | Transaction | Start Date | Ownership |
|---|---|---|---|---|---|---|---|---|---|
| 0 | 4651 | 70742.0 | — | Sale at price 15.21 per share. | BOUGHTON SOLEIL | Officer | — | 2026-02-27 00:00:00 | D |
| 1 | 794002 | — | — | Stock Award(Grant) at price 0.00 per share. | DUDUM ANDREW | Chief Executive Officer | — | 2026-02-23 00:00:00 | D |
| 2 | 273794 | — | — | Stock Award(Grant) at price 0.00 per share. | BOUGHTON SOLEIL | Officer | — | 2026-02-23 00:00:00 | D |
| 3 | 410690 | — | — | Stock Award(Grant) at price 0.00 per share. | OKUPE OLUYEMI | Chief Financial Officer | — | 2026-02-23 00:00:00 | D |
| 4 | 365058 | — | — | Stock Award(Grant) at price 0.00 per share. | CHI MICHAEL Y | Chief Operating Officer | — | 2026-02-23 00:00:00 | D |
| 5 | 5262 | 26363.0 | — | Conversion of Exercise of derivative security at price 5.01 per share. | OKUPE OLUYEMI | Chief Financial Officer | — | 2026-02-03 00:00:00 | D |
| 6 | 5262 | 139108.0 | — | Sale at price 26.44 per share. | OKUPE OLUYEMI | Chief Financial Officer | — | 2026-02-03 00:00:00 | D |
| 7 | 9067 | 56836.0 | — | Conversion of Exercise of derivative security at price 5.01 - 11.53 per share. | OKUPE OLUYEMI | Chief Financial Officer | — | 2026-01-20 00:00:00 | D |
| 8 | 9067 | 275114.0 | — | Sale at price 30.34 per share. | OKUPE OLUYEMI | Chief Financial Officer | — | 2026-01-20 00:00:00 | D |
| 9 | 5986 | 54818.0 | — | Conversion of Exercise of derivative security at price 5.01 - 11.53 per share. | OKUPE OLUYEMI | Chief Financial Officer | — | 2026-01-05 00:00:00 | D |
Financials
| Line Item | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| TaxEffectOfUnusualItems | 931.77K | 0.00 | 0.00 | 0.00 |
| TaxRateForCalcs | 0.21 | 0.21 | 0.21 | 0.00 |
| NormalizedEBITDA | 155.68M | 78.99M | -19.94M | -61.22M |
| TotalUnusualItems | 4.44M | 70.00K | 3.80M | |
| TotalUnusualItemsExcludingGoodwill | 4.44M | 70.00K | 3.80M | |
| NetIncomeFromContinuingOperationNetMinorityInterest | 128.37M | 126.04M | -23.55M | -65.68M |
| ReconciledDepreciation | 54.50M | 17.09M | 9.52M | 7.47M |
| ReconciledCostOfRevenue | 614.26M | 303.38M | 157.05M | 118.19M |
| EBITDA | 160.12M | 78.99M | -19.94M | -61.22M |
| EBIT | 105.61M | 61.90M | -29.45M | -68.70M |
| NetInterestIncome | 0.00 | |||
| InterestExpense | 0.00 | |||
| NormalizedIncome | 124.86M | 126.04M | -23.55M | -65.68M |
| NetIncomeFromContinuingAndDiscontinuedOperation | 128.37M | 126.04M | -23.55M | -65.68M |
| TotalExpenses | 2.24B | 1.41B | 901.45M | 595.61M |
| TotalOperatingIncomeAsReported | 105.61M | 61.90M | -29.45M | -68.70M |
| DilutedAverageShares | 258.23M | 236.81M | 209.34M | 204.52M |
| BasicAverageShares | 224.96M | 215.94M | 209.34M | 204.52M |
| DilutedEPS | 0.51 | 0.53 | -0.11 | -0.32 |
| BasicEPS | 0.57 | 0.58 | -0.11 | -0.32 |
| DilutedNIAvailtoComStockholders | 128.37M | 126.04M | -23.55M | -65.68M |
| NetIncomeCommonStockholders | 128.37M | 126.04M | -23.55M | -65.68M |
| NetIncome | 128.37M | 126.04M | -23.55M | -65.68M |
| NetIncomeIncludingNoncontrollingInterests | 128.37M | 126.04M | -23.55M | -65.68M |
| NetIncomeContinuousOperations | 128.37M | 126.04M | -23.55M | -65.68M |
| TaxProvision | -4.44M | -54.33M | 1.98M | -31.00K |
| PretaxIncome | 123.92M | 71.71M | -21.57M | -65.71M |
| OtherIncomeExpense | 18.31M | 9.81M | 7.88M | 2.99M |
| OtherNonOperatingIncomeExpenses | 13.87M | 9.81M | 7.88M | 2.99M |
| GainOnSaleOfSecurity | 4.44M | 70.00K | 3.80M | |
| NetNonOperatingInterestIncomeExpense | 0.00 | |||
| InterestExpenseNonOperating | 0.00 | |||
| OperatingIncome | 105.61M | 61.90M | -29.45M | -68.70M |
| OperatingExpense | 1.63B | 1.11B | 744.40M | 477.42M |
| OtherOperatingExpenses | 286.44M | 185.80M | 119.86M | 77.40M |
| ResearchAndDevelopment | 149.30M | 78.82M | 48.23M | 29.24M |
| SellingGeneralAndAdministration | 1.19B | 846.61M | 576.32M | 370.78M |
| SellingAndMarketingExpense | 919.30M | 678.84M | 446.44M | 272.59M |
| GeneralAndAdministrativeExpense | 272.72M | 167.77M | 129.88M | 98.19M |
| OtherGandA | 272.72M | 167.77M | 129.88M | 98.19M |
| GrossProfit | 1.73B | 1.17B | 714.95M | 408.72M |
| CostOfRevenue | 614.26M | 303.38M | 157.05M | 118.19M |
| TotalRevenue | 2.35B | 1.48B | 872.00M | 526.92M |
| OperatingRevenue | 2.35B | 1.48B | 872.00M | 526.92M |
| Line Item | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| OrdinarySharesNumber | 227.25M | 220.84M | 213.48M | 208.43M |
| ShareIssued | 227.25M | 220.84M | 213.48M | 208.43M |
| NetDebt | 743.96M | |||
| TotalDebt | 1.12B | 11.35M | 9.95M | 5.31M |
| TangibleBookValue | 66.49M | 320.58M | 214.57M | 179.02M |
| InvestedCapital | 1.51B | 476.72M | 344.03M | 311.74M |
| WorkingCapital | 363.21M | 174.46M | 176.59M | 168.65M |
| NetTangibleAssets | 66.49M | 320.58M | 214.57M | 179.02M |
| CapitalLeaseObligations | 148.01M | 11.35M | 9.95M | 5.31M |
| CommonStockEquity | 540.93M | 476.72M | 344.03M | 311.74M |
| TotalCapitalization | 1.51B | 476.72M | 344.03M | 311.74M |
| TotalEquityGrossMinorityInterest | 540.93M | 476.72M | 344.03M | 311.74M |
| StockholdersEquity | 540.93M | 476.72M | 344.03M | 311.74M |
| GainsLossesNotAffectingRetainedEarnings | 2.29M | -324.00K | -124.00K | -277.00K |
| OtherEquityAdjustments | 2.29M | -324.00K | -124.00K | -277.00K |
| RetainedEarnings | -113.77M | -242.14M | -368.18M | -344.63M |
| AdditionalPaidInCapital | 652.38M | 719.15M | 712.31M | 656.63M |
| CapitalStock | 23.00K | 22.00K | 21.00K | 21.00K |
| CommonStock | 23.00K | 22.00K | 21.00K | 21.00K |
| TotalLiabilitiesNetMinorityInterest | 1.61B | 230.82M | 97.16M | 54.60M |
| TotalNonCurrentLiabilitiesNetMinorityInterest | 1.21B | 9.46M | 8.69M | 6.66M |
| OtherNonCurrentLiabilities | 64.74M | 22.00K | 3.01M | 2.63M |
| PreferredSecuritiesOutsideStockEquity | 0.00 | |||
| NonCurrentDeferredLiabilities | 28.86M | 0.00 | ||
| NonCurrentDeferredTaxesLiabilities | 28.86M | 0.00 | ||
| LongTermDebtAndCapitalLeaseObligation | 1.12B | 9.46M | 8.67M | 3.65M |
| LongTermCapitalLeaseObligation | 143.17M | 9.46M | 8.67M | 3.65M |
| LongTermDebt | 972.58M | |||
| CurrentLiabilities | 404.43M | 221.37M | 88.47M | 47.94M |
| OtherCurrentLiabilities | 3.65M | |||
| CurrentDeferredLiabilities | 127.16M | 75.28M | 7.73M | 1.47M |
| CurrentDeferredRevenue | 127.16M | 75.28M | 7.73M | 1.47M |
| CurrentDebtAndCapitalLeaseObligation | 4.84M | 1.89M | 1.28M | 1.66M |
| CurrentCapitalLeaseObligation | 4.84M | 1.89M | 1.28M | 1.66M |
| PayablesAndAccruedExpenses | 268.78M | 144.19M | 79.45M | 44.81M |
| CurrentAccruedExpenses | 68.88M | 50.86M | 28.97M | 11.48M |
| Payables | 199.90M | 93.33M | 50.48M | 33.33M |
| OtherPayable | 46.99M | 7.41M | 42.83M | |
| TotalTaxPayable | 9.64M | 2.15M | 2.01M | 963.00K |
| AccountsPayable | 143.28M | 91.18M | 43.07M | 32.36M |
| TotalAssets | 2.15B | 707.54M | 441.19M | 366.34M |
| TotalNonCurrentAssets | 1.39B | 311.71M | 176.13M | 149.75M |
| OtherNonCurrentAssets | 29.68M | 1.00M | 947.00K | 889.00K |
| NonCurrentDeferredAssets | 82.71M | 61.60M | 0.00 | |
| NonCurrentDeferredTaxesAssets | 82.71M | 61.60M | 0.00 | |
| InvestmentsAndAdvances | 351.26M | 0.00 | ||
| InvestmentinFinancialAssets | 351.26M | 0.00 | ||
| AvailableForSaleSecurities | 351.26M | |||
| GoodwillAndOtherIntangibleAssets | 474.44M | 156.14M | 129.46M | 132.72M |
| OtherIntangibleAssets | 196.12M | 43.41M | 18.57M | 21.84M |
| Goodwill | 278.32M | 112.73M | 110.88M | 110.88M |
| NetPPE | 448.98M | 92.96M | 45.73M | 16.14M |
| AccumulatedDepreciation | -52.59M | -24.50M | -12.24M | -6.24M |
| GrossPPE | 501.56M | 117.46M | 57.98M | 22.38M |
| Leases | 15.93M | 10.93M | 2.26M | 155.00K |
| OtherProperties | 351.33M | 44.65M | 24.50M | 6.57M |
| MachineryFurnitureEquipment | 134.31M | 61.88M | 31.22M | 15.65M |
| Properties | 0.00 | 0.00 | 0.00 | 0.00 |
| CurrentAssets | 767.64M | 395.83M | 265.05M | 216.59M |
| OtherCurrentAssets | 4.37M | 400.00K | 4.20M | 1.78M |
| CurrentDeferredAssets | 0.00 | |||
| PrepaidAssets | 73.50M | 24.67M | 10.66M | 10.39M |
| Inventory | 80.13M | 64.43M | 22.46M | 21.56M |
| FinishedGoods | 26.98M | 35.08M | 15.22M | 16.48M |
| RawMaterials | 53.15M | 29.35M | 7.24M | 5.08M |
| Receivables | 32.15M | 6.08M | 6.75M | 3.23M |
| AccountsReceivable | 32.15M | 6.08M | 6.75M | 3.23M |
| CashCashEquivalentsAndShortTermInvestments | 577.49M | 300.25M | 220.98M | 179.62M |
| OtherShortTermInvestments | 348.88M | 79.67M | 124.32M | 132.85M |
| CashAndCashEquivalents | 228.62M | 220.58M | 96.66M | 46.77M |
| Line Item | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| FreeCashFlow | 57.41M | 198.33M | 46.99M | -33.78M |
| RepurchaseOfCapitalStock | -89.96M | -83.04M | -2.00M | 0.00 |
| RepaymentOfDebt | 0.00 | 0.00 | ||
| IssuanceOfDebt | 970.00M | 0.00 | 0.00 | 0.00 |
| IssuanceOfCapitalStock | 0.00 | 0.00 | 272.69M | |
| CapitalExpenditure | -242.59M | -52.75M | -26.49M | -7.25M |
| InterestPaidSupplementalData | 0.00 | 0.00 | ||
| IncomeTaxPaidSupplementalData | 23.16M | 7.92M | 1.11M | 636.00K |
| EndCashPosition | 228.62M | 221.44M | 97.52M | 47.63M |
| BeginningCashPosition | 221.44M | 97.52M | 47.63M | 72.64M |
| EffectOfExchangeRateChanges | 2.51M | -270.00K | -11.00K | -53.00K |
| ChangesInCash | 4.67M | 124.19M | 49.90M | -24.96M |
| FinancingCashFlow | 729.62M | -107.84M | -11.47M | -33.13M |
| CashFlowFromContinuingFinancingActivities | 729.62M | -107.84M | -11.47M | -33.13M |
| NetOtherFinancingCharges | -167.89M | -55.69M | -14.10M | -36.55M |
| ProceedsFromStockOptionExercised | 17.47M | 30.89M | 4.62M | 3.42M |
| NetPreferredStockIssuance | 0.00 | 0.00 | ||
| PreferredStockIssuance | 0.00 | 0.00 | ||
| NetCommonStockIssuance | -89.96M | -83.04M | -2.00M | 0.00 |
| CommonStockPayments | -89.96M | -83.04M | -2.00M | 0.00 |
| CommonStockIssuance | 0.00 | 0.00 | 272.69M | |
| NetIssuancePaymentsOfDebt | 970.00M | 0.00 | 0.00 | 0.00 |
| NetLongTermDebtIssuance | 970.00M | 0.00 | 0.00 | 0.00 |
| LongTermDebtPayments | 0.00 | 0.00 | ||
| LongTermDebtIssuance | 970.00M | 0.00 | 0.00 | 0.00 |
| InvestingCashFlow | -1.02B | -19.05M | -12.11M | 34.70M |
| CashFlowFromContinuingInvestingActivities | -1.02B | -19.05M | -12.11M | 34.70M |
| NetInvestmentPurchaseAndSale | -637.14M | 49.10M | 14.39M | 42.41M |
| SaleOfInvestment | 108.70M | 209.66M | 171.62M | 230.10M |
| PurchaseOfInvestment | -745.84M | -160.56M | -157.24M | -187.70M |
| NetBusinessPurchaseAndSale | -145.23M | -15.40M | 0.00 | -459.00K |
| PurchaseOfBusiness | -145.23M | -15.40M | 0.00 | -459.00K |
| NetIntangiblesPurchaseAndSale | -16.55M | -11.10M | -9.27M | -4.53M |
| PurchaseOfIntangibles | -16.55M | -11.10M | -9.27M | -4.53M |
| NetPPEPurchaseAndSale | -226.04M | -41.66M | -17.22M | -2.71M |
| PurchaseOfPPE | -226.04M | -41.66M | -17.22M | -2.71M |
| OperatingCashFlow | 300.01M | 251.08M | 73.48M | -26.53M |
| CashFlowFromContinuingOperatingActivities | 300.01M | 251.08M | 73.48M | -26.53M |
| ChangeInWorkingCapital | -29.16M | 78.62M | 20.82M | -14.20M |
| ChangeInOtherWorkingCapital | 51.60M | 67.55M | 6.26M | -1.72M |
| ChangeInOtherCurrentLiabilities | -1.91M | -2.44M | -1.93M | -1.60M |
| ChangeInOtherCurrentAssets | -518.00K | -56.00K | -58.00K | 17.00K |
| ChangeInPayablesAndAccruedExpense | -12.76M | 64.68M | 23.85M | 3.45M |
| ChangeInAccruedExpense | -43.05M | 23.79M | 16.52M | 909.00K |
| ChangeInPayable | 30.30M | 40.88M | 7.32M | 2.54M |
| ChangeInAccountPayable | 30.30M | 43.71M | 7.32M | 12.72M |
| ChangeInPrepaidAssets | -51.86M | -9.49M | -6.39M | -6.33M |
| ChangeInInventory | -13.72M | -41.61M | -902.00K | -8.00M |
| OtherNonCashItems | 29.95M | 2.90M | 5.88M | 2.37M |
| StockBasedCompensation | 135.24M | 92.32M | 66.08M | 42.82M |
| UnrealizedGainLossOnInvestmentSecurities | -4.44M | 0.00 | 0.00 | |
| AssetImpairmentCharge | 531.00K | 114.00K | 429.00K | 1.13M |
| AmortizationOfSecurities | -2.03M | -4.36M | -5.69M | 146.00K |
| DeferredTax | -12.96M | -61.65M | -13.00K | -594.00K |
| DeferredIncomeTax | -12.96M | -61.65M | -13.00K | -594.00K |
| DepreciationAmortizationDepletion | 54.50M | 17.09M | 9.52M | 7.47M |
| DepreciationAndAmortization | 54.50M | 17.09M | 9.52M | 7.47M |
| OperatingGainsLosses | 154.00K | |||
| GainLossOnInvestmentSecurities | 154.00K | |||
| NetIncomeFromContinuingOperations | 128.37M | 126.04M | -23.55M | -65.68M |
SEC Filings
Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.
Public Trades for HIMS
| Date | User | Broker | Pattern | Type | Position Size | Entry Price | Trade P&L | Status |
|---|